Pfizer CEO’s Three Tips for Research Success

Jeff Kindler in today's Wall Street Journal's Health Blog gives this summary of what he feels will lead to success in today's Pharma industry:

1. Each group should have between 100 and 150 scientists — few enough that they can all get together in the cafeteria to talk about what they’re doing.

2. Each should be run by a chief scientific officer prominent in the field.

3. They should be left alone “to create their own culture,” and should be judged, for the most part, on a single metric: Discovering drugs that demonstrate proof of concept.

Bottom line - Kindler's blueprint for R&D success looks striking similar to what GSK is currently doing.